Clinic-Level Screening
Rate Changes
|
What
are trends in B/C screening rates over time across health system
clinics?
What
are baseline B/C screening rates in clinics?
Are
clinics’ screening rates increasing over time?
Are clinics
meeting targets for B/C screening?
|
X
|
|
What
are the characteristics of the health systems and clinics where
EBIs are being implemented?
|
X
|
|
Patient Reach / Patient
Demographics and Eligibility Criteria
|
What
is the reach of the B/C screening program via health systems and
their clinics?
How
many health systems and their clinics are grantees partnering
with for health systems change?
How
many women within the age-eligible group for screening are
served by these clinics?
How
many providers work at these clinics?
What is the
geographic location of health system clinics?
|
X
|
|
EBIs to Support B&C
Screening
|
What
EBIs are grantees implementing and/or enhancing within health
system clinics?
Are
B/C resources used to support EBI implementation?
What
EBIs are being implemented with B/C resources?
Are multiple EBIs
being implemented within clinics? If so, which combinations are
used?
|
X
|
|
What
EBIs (or combination of EBIs) are associated with greater
increases in B/C screening within health system clinics?
|
X
|
|
To
what extent is implementation of the EBIs sustainable
without NBCCEDP funding?
|
X
|
|
Partnerships to Support
Screening
|
What
are the characteristics of grantees’ screening provider
sites delivering B/C clinical services?
|
|
X
|
What
are the characteristics of the non-health system/clinic partners
that grantees engage to support the B/C program?
What
types and how many non-health system/clinic partners do grantees
engage to support the program?
Are
partnerships already established or newly formed?
Are
partnerships formalized (e.g., MOU, contract)?
How
much funding is budgeted to support these partnerships?
What types of
activities do these partners conduct?
|
|
X
|
Community Outreach and
Patient Navigation
|
To
what extent are health systems and their clinics utilizing
community health workers to reach priority?
|
X
|
X
|
To
what extent are health systems and their clinics utilizing
patient navigators to support priority populations?
How
many women were served through patient navigation (including
those who did and did not receive screening services at B/C
provider sites)?
How
many women receive patient navigation at partner health system
clinic sites where EBIs are delivered
What patient
navigation activities were delivered to patients?
|
X
|
X
|
Support of Healthy
Lifestyle Behaviors
|
Do
health system clinic partners have a comprehensive B/C screening
policy in place?
|
X
|
|
Grantee Infrastructure
(Including Health IT)
|
Are
clinic data monitored for quality?
What
is clinics’ confidence in screening rates generated by
EHRs?
Do
health systems validate their screening rates?
What
are the known data issues?
What improvements
have been made to EHR systems?
|
X
|
X
|
What
types of health IT support are grantees providing to health
systems?
|
|
X
|
Grantees’
Monitoring and Evaluation
|
What
monitoring and evaluation activities are grantees implementing?
Are
grantees using data to inform programmatic decision-making
and/or clinic-level service delivery?
What
types of data are used by grantees?
How
often are data used?
Are
grantees using data dashboards to inform decision-making? If so,
what decisions are influenced by data dashboards?
How frequently are
grantees monitoring screening rates at clinics?
|
X
|
X
|
What
metrics, if any, are used to track programmatic progress over
time?
|
|
X
|
Program Management
|
What
barriers and facilitators do grantees encounter when managing,
implementing, and/or evaluating their programs?
|
|
X
|
What
are grantees’ technical assistance and training needs?
|
|
X
|
What
non-CDC financial resources do grantees have to support the
NBCCEDP?
|
|
X
|
Incidence, Mortality,
and Disparities
|
Are
grantees tracking incidence and/or mortality rates for priority
populations?
|
|
X
|
Are
grantees tracking disparities for priority populations?
|
|
X
|